The efficacy of lopinavir in individuals experiencing protease inhibitor failure.
Gilleece
Yvonne C
YC
Qazi
Nad A
NA
Morlese
John F
JF
Mandalia
Sundhiya
S
Gazzard
Brian G
BG
Pozniak
Anton L
AL
Nelson
Mark R
MR
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000628:therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015497:HIV-1; D006801:Humans; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000627:therapeutic use; D011744:Pyrimidinones / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D017211:Treatment Failure
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011480:Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir